Cargando…

Learning From Success and Failure: Biologics for Non-approved Skin Diseases

The impressive potential of biologics has been demonstrated in psoriasis, hidradenitis suppurativa, and urticaria. Numerous biologicals are entering the field for a restricted number of skin disorders. Off-label use of biologics in other recalcitrant skin diseases has increased. Mounting data point...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speeckaert, Reinhart, Lambert, Jo, van Geel, Nanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694799/ https://www.ncbi.nlm.nih.gov/pubmed/31440261 http://dx.doi.org/10.3389/fimmu.2019.01918

Ejemplares similares

From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?
por: Belpaire, Arno, et al.
Publicado: (2022)

Autoimmunity in Segmental Vitiligo
por: Speeckaert, Reinhart, et al.
Publicado: (2020)

A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes
por: Speeckaert, Reinhart, et al.
Publicado: (2023)

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review
por: Speeckaert, Reinhart, et al.
Publicado: (2022)

Hypomelanoses in Children
por: van Geel, Nanja, et al.
Publicado: (2013)

Patients’ Perception of Vitiligo Severity
por: VAN GEEL, Nanja, et al.
Publicado: (2021)

Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
por: Lambert, Jo L. W., et al.
Publicado: (2021)

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
por: Chevolet, Ines, et al.
Publicado: (2015)

A Review of Non-cultured Epidermal Cellular Grafting in Vitiligo
por: van Geel, Nanja, et al.
Publicado: (2011)

JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
por: Alves de Medeiros, Ana Karina, et al.
Publicado: (2016)

The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
por: van Geel, Nanja, et al.
Publicado: (2022)

Editorial: Immunology of Vitiligo
por: Seneschal, Julien, et al.
Publicado: (2021)

Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA molecules and anti-miRNAs in the therapeutic treatment of psoriasis
por: Bracke, Stefanie, et al.
Publicado: (2011)

Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?
por: Delrue, Charlotte, et al.
Publicado: (2023)

A Perspective on the Success and Failure of BCG
por: Kumar, Pawan
Publicado: (2021)

Immunological Aspects of Approved MS Therapeutics
por: Rommer, Paulus S., et al.
Publicado: (2019)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Corrigendum: A Perspective on the Success and Failure of BCG
por: Kumar, Pawan
Publicado: (2022)

Assessment of Non-cultured Autologous Epidermal Cell Grafting Resuspended in Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism Lesions: A Randomized Clinical Trial
por: BERTOLOTTI, Antoine, et al.
Publicado: (2021)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Seek success, not approval: the only approval you need is yours
por: Elko, Kevin, et al.
Publicado: (2010)

Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval
por: Martini, Alberto, et al.
Publicado: (2023)

Commentary: Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases
por: Thielemans, Raïsa, et al.
Publicado: (2023)

Editorial: Immunometabolism of T cells in skin infection, autoimmunity and cancer biology
por: Peng, Lu, et al.
Publicado: (2023)

Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)
por: van Geel, N., et al.
Publicado: (2020)

The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach
por: Delrue, Charlotte, et al.
Publicado: (2022)

Vitamin D Deficiency: An Underestimated Factor in Sepsis?
por: Delrue, Charlotte, et al.
Publicado: (2023)

Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires
por: Petersen, Brian M., et al.
Publicado: (2021)

Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
por: Li, Chaonan, et al.
Publicado: (2022)

Complement Activation in Inflammatory Skin Diseases
por: Giang, Jenny, et al.
Publicado: (2018)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k0gr02lf8qi1070tqekpehln2h